composição farmacêutica, uso da mesma, e, processo para a fabricação de uma formulação

The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.

Saved in:
Bibliographic Details
Main Authors MARTIN WHITAKER, HIEP HUATAN, RICHARD ROSS
Format Patent
LanguagePortuguese
Published 23.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
Bibliography:Application Number: BR20141120008